Our Pricing

Prescription Diet Injections UK: Clinical Weight Loss Treatment Online

Published on: June 03, 2026

When you need prescription diet injections UK online, Cured Pharmacy offers genuine MHRA-licensed treatments including Mounjaro, Wegovy, and Saxenda from £135.00. Our UK-registered clinical team provides free consultations in under three minutes, with discreet next-day delivery across the UK.

How Prescription Diet Injections Work in the UK

Prescription diet injections available in the UK work by mimicking natural gut hormones called incretins, which regulate appetite and blood sugar levels. The most effective treatments—tirzepatide (Mounjaro), semaglutide (Wegovy), and liraglutide (Saxenda)—are GLP-1 receptor agonists that signal to your brain when you're full, slow gastric emptying, and reduce food cravings [1].

Mounjaro represents the latest advancement as the UK's first dual GIP/GLP-1 receptor agonist, activating two hormone pathways simultaneously. In the SURMOUNT-1 trial, participants achieved an average body weight reduction of 20.9% over 72 weeks on the 15mg dose—significantly higher than single-pathway alternatives [1]. This dual mechanism explains why tirzepatide produces superior clinical outcomes compared to earlier GLP-1 treatments.

All prescription diet injections require weekly or daily subcutaneous administration, typically in the abdomen, thigh, or upper arm. Your UK prescriber will determine the appropriate starting dose and titration schedule based on your medical history, current medications, and weight loss goals.

Comparing Prescription Diet Injections UK: Mounjaro vs Wegovy vs Saxenda

The three main prescription diet injections licensed by the MHRA in the UK differ in their active ingredients, dosing frequency, and clinical efficacy profiles. Understanding these differences helps you and your prescriber choose the most appropriate treatment.

Mounjaro (tirzepatide) offers the highest average weight loss in clinical trials, with participants losing up to 22.5% of their body weight over 72 weeks in the SURPASS-3 trial [2]. The once-weekly injection uses a dual GIP/GLP-1 mechanism that many UK prescribers now consider the gold standard for prescription weight management.

Wegovy (semaglutide) is also administered once weekly and demonstrated an average 14.9% body weight reduction over 68 weeks in the STEP-1 trial [3]. As a pure GLP-1 receptor agonist, it's been available longer in the UK market and has an established safety profile with millions of patient-years of experience.

Saxenda (liraglutide) requires daily injections and typically produces more modest results—an average 8% body weight reduction over 56 weeks in the SCALE trial [4]. However, the daily dosing allows for more flexible titration, and some patients prefer the shorter-acting formulation.

Which Prescription Diet Injection Is Right for You?

Your UK prescriber will assess several factors when recommending a specific treatment: your BMI, previous weight loss attempts, medical conditions like type 2 diabetes or cardiovascular disease, current medications, and personal preferences regarding injection frequency. Patients with type 2 diabetes may benefit more from Mounjaro's superior glycaemic control, while those new to injectable treatments might prefer starting with Saxenda's daily dosing to assess tolerance.

At Cured Pharmacy, our clinical team reviews your complete medical history during the free online consultation. Subject to prescriber approval, you'll receive the most clinically appropriate prescription diet injection for your individual circumstances, with transparent pricing confirmed before you proceed.

Clinical Efficacy: What the UK Trials Show

The prescription diet injections available through UK pharmacies are supported by extensive randomised controlled trials involving tens of thousands of participants. These studies provide the evidence base that informed MHRA licensing decisions and NICE guidance on weight management.

The SURMOUNT trial programme for tirzepatide demonstrated dose-dependent weight loss, with the 15mg weekly dose producing an average 20.9% reduction in body weight over 72 weeks [1]. Importantly, 63% of participants achieved at least 20% weight loss—a threshold associated with significant improvements in obesity-related comorbidities including sleep apnoea, osteoarthritis, and fatty liver disease.

Semaglutide's STEP trial programme showed that 69% of participants on Wegovy achieved at least 10% body weight reduction, compared to 12% on placebo [3]. The treatment also improved cardiovascular risk markers including blood pressure, inflammatory markers, and lipid profiles.

Real-world UK data from NHS pilots mirrors these trial outcomes, with average weight loss of 12-15% at 12 months for patients who maintain treatment adherence. Your individual results will depend on adherence to the prescribed regimen, dietary modifications, and physical activity levels.

Long-Term Weight Maintenance with Prescription Diet Injections

Clinical trials demonstrate that weight loss plateaus typically occur between 60-72 weeks of treatment, after which most patients maintain their reduced weight while continuing therapy. The STEP-4 trial showed that participants who discontinued semaglutide regained approximately two-thirds of their lost weight within 52 weeks, highlighting the importance of ongoing treatment for sustained results [3].

UK prescribers typically recommend viewing prescription diet injections as long-term management tools rather than short-term solutions. Most patients require ongoing treatment to maintain weight loss, similar to how other chronic conditions like hypertension or diabetes require continuous medication.

Starting Prescription Diet Injections: The UK Clinical Process

All prescription diet injections in the UK are prescription-only medicines (POMs) that require clinical assessment by a GMC-registered prescriber before dispensing. At Cured Pharmacy, this process begins with a comprehensive online consultation that takes under three minutes to complete.

Our clinical questionnaire covers your medical history, current medications, previous weight loss attempts, cardiovascular risk factors, and contraindications specific to GLP-1 treatments. You'll need to provide accurate information about conditions including medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastroparesis, and inflammatory bowel disease, as these may preclude treatment.

Once submitted, a UK-registered prescriber reviews your consultation within hours. If clinically appropriate, they'll issue a private prescription and recommend the optimal starting dose. For Mounjaro, this is typically 2.5mg weekly for four weeks, then 5mg weekly, with potential titration to higher doses based on tolerance and efficacy. Wegovy follows a similar gradual escalation protocol to minimise gastrointestinal side effects.

Your prescription is then dispensed by our GPhC-registered pharmacy (registration number 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). Medications are sourced exclusively from UK-licensed wholesalers and dispatched in discreet packaging with next-day delivery options across the UK.

Side Effects and Safety Considerations for Diet Injections UK

The most common side effects of prescription diet injections are gastrointestinal: nausea, diarrhoea, constipation, vomiting, and abdominal discomfort. In clinical trials, these symptoms affected 30-50% of participants but were typically mild to moderate and diminished over 4-8 weeks as the body adapted [1][3]. The gradual dose escalation protocols used in the UK specifically aim to minimise these effects.

Serious adverse events are rare but include pancreatitis (occurring in approximately 0.2% of patients), gallbladder disease, and hypoglycaemia when used with insulin or sulfonylureas. The MHRA requires prescribers to counsel patients on warning signs including severe abdominal pain, persistent vomiting, and symptoms of acute pancreatitis [5].

Thyroid C-cell tumours were observed in rodent studies of GLP-1 receptor agonists, leading to a contraindication in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. However, no causal relationship has been established in human populations after millions of patient-years of exposure [5].

Your UK prescriber will assess your individual risk profile before prescribing. Patients with a history of severe gastroparesis, inflammatory bowel disease, or diabetic retinopathy should be monitored closely. Pregnant or breastfeeding individuals should not use prescription diet injections, and women of childbearing age should use effective contraception during treatment.

Managing Side Effects: Practical Guidance

Most patients find that gastrointestinal side effects resolve within the first month of treatment. Eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and taking the injection on the same day each week can help minimise nausea and digestive discomfort.

If side effects persist or worsen, contact your prescriber before your next dose. They may recommend maintaining your current dose for an additional month before escalating, or in some cases, temporarily reducing the dose. Never adjust your dose without prescriber guidance, as this may affect both efficacy and tolerability.

Pricing and Accessing Prescription Diet Injections UK Through Cured Pharmacy

Cured Pharmacy offers transparent upfront pricing for all prescription diet injections, with costs displayed before you complete your clinical consultation. This pricing structure includes the medication, prescriber consultation, and discreet delivery—no hidden fees or subscription requirements.

Our pricing reflects the UK's most competitive rates for genuine MHRA-licensed treatments. We source directly from UK-licensed wholesalers and maintain efficient online operations, allowing us to offer lower prices than traditional high-street pharmacies while maintaining the same regulatory standards and clinical oversight.

Prescription diet injections are not currently available on the NHS for weight management alone (except in specialist weight management services in some areas). Most UK patients access these treatments privately, either through online pharmacies like Cured Pharmacy or traditional private clinics. Our model eliminates the need for in-person appointments while maintaining full compliance with GPhC and MHRA regulations.

Once your prescription is approved, medication typically arrives within 24 hours via tracked courier in unmarked packaging. Repeat prescriptions can be arranged through your online account, with automatic reminders before your supply runs out. Our UK-based patient support team is available on (+44) 116 4646009 for any questions about your treatment.

Why Choose Cured Pharmacy for Prescription Diet Injections UK

As a fully registered UK pharmacy (GPhC 9012511), we operate under the same regulatory framework as high-street pharmacies but offer the convenience of online access and competitive pricing. Our clinical team includes GMC-registered prescribers and GPhC-registered pharmacists who specialise in weight management treatments.

We guarantee 100% genuine UK-licensed medications—never grey market imports or compounded alternatives. Every prescription diet injection we dispense comes from MHRA-approved manufacturers via UK-licensed wholesalers, with full batch traceability and cold-chain integrity maintained throughout the supply process.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Medicines and Healthcare products Regulatory Agency. (2023). GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued. Drug Safety Update, 16(9). https://www.gov.uk/drug-safety-update [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle factors.